Network-Based vs. Standardized Cognitive Behavioral Therapy in Chronic Primary Pain

NCT ID: NCT06784141

Last Updated: 2025-05-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

75 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-30

Study Completion Date

2027-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cognitive-behavioral therapy (CBT) has been shown to be an effective treatment for chronic primary pain (CPP), but overall effect sizes are small to moderate. Process orientation, personalization, and data-driven clinical decision-making may be able to address the heterogeneity among people with CPP and are thus promising ways to increase the effectiveness of CBT for CPP. In a previous study, the feasibility of personalized CBT for CPP using network analysis was investigated. Based on this work, the present study aims to compare this personalized CBT with a standardized CBT as treatment-as-usual condition.

In a balanced repeated measures design, a personalized CBT intervention is compared with a standardized CBT intervention. Participants are patients with CPP in German outpatient clinics. Primary and secondary outcome measures (disability, treatment expectations, pain intensity, working alliance, and side effects) will be collected after each study period. In addition, a SCED with randomized baselines will be embedded in the study, in which changes in processes relevant to chronic pain will be evaluated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Hypothesis:

Personalized CBT will achieve a comparable treatment effect to the standardized CBT condition, i.e. a stronger reduction in the outcome measures (intercept and slope).

Participants:

Recruitment takes place at selected university outpatient clinics throughout Germany. Patients will be recruited via the waiting list of the university's outpatient clinic, in cooperation with other currently running studies at the same university recruiting chronic pain patients, and via various media (e.g. newspaper articles) and doctors' offices. Study therapists will be recruited in the university's outpatient clinic as well. Inclusion criteria for patients are at least 18 years of age, having access to a smartphone, and the main diagnosis of chronic pain. The diagnosis will be checked using the brief version of the Diagnostic Interview for Mental Disorders (Mini-DIPS). For patients recruited via the waiting list, screening for suitability will take place during the first consultation at the university psychotherapy training center's outpatient clinic. Suitable participants will be informed about the study and referred if they agree to be contacted. Furthermore, patients that had to be excluded from other currently running studies will be referred if they agreed to be contacted as well.

Procedure \& Measures:

Counterbalanced Repeated Measures Design: At this level, the primary outcome measure is pain disability index (PDI) and the WHO Disability Assessment Schedule 2.0 (WHODAS 2.0). Therapeutic alliance (Helping Alliance Questionnaire (HAQ), Working Alliance Inventory Short Revised (WAI-R); both therapist and patient version) and side effects (Negative Effects Questionnaire, NEQ) as well as expectations (Patient Questionnaire on Therapy Expectation and Evaluation, PATHEV) are collected as secondary outcome variables. These are collected before and after the diagnostic phase (A), after both interventions (C1, C2) and at follow-up (3 months). The HAQ, WAI-R, and NEQ constitute exceptions in this context. As these instruments pertain to the therapeutic relationship or the overall therapy process, they are not administered prior to the diagnostic phase, since no therapeutic contact has yet taken place. In addition, the therapist's case concept and a Perceived Causal Network (PECAN) of the therapist are collected after the diagnostic phase. Additional outcome measures are collected before the diagnostic phase (A), before the 3th baseline (B3) and at follow-up. As additional outcome measures the Depression Anxiety Stress Scale (DASS-21), the German Pain Solutions Questionnaire (PaSol), the Patient Global Impression of Change (PGIC) and Pain Self-Efficacy Questionnaire will be assed.

SCED: The participants begin with the standard diagnostic phase of routine clinical care (phase B, 5 sessions) with psychoeducation and the development of therapy goals. After a randomized baseline (phase A1, 1-3 weeks), the intervention phase (phase C) begins. Participants are randomly assigned to one of two groups. Group 1 begins with personalized CBT followed by standardized CBT whereas Group 2 begins with standardized CBT followed by personalized CBT. A second baseline takes place in both groups after the first intervention before the beginning of the second intervention (A2, randomized 1-3 weeks). After the two different therapeutic phases, another baseline (A3, 2 weeks) and afterwards an EMA phase of 3 weeks will be completed. In addition, there are two booster sessions with the therapist one and three months after the last therapy session. During the EMA phases, data will be collected 6 times per day. In all other phases, the questionnaires are asked 3 times a week.

Analysis:

To evaluate group differences, a multilevel analysis (MLM) is calculated to take the nested data structure into account. The effects within the individual participant are calculated at level 1 and across the participants at level 2. To determine the required sample size, we performed a data simulation assuming a normal distribution with two predictors in the MLM: Treatment and order of treatment. The simulation revealed that a sample size of 59 participants is required, with a power of 0.80 aimed for to detect small effect sizes. Based on the dropout rate observed in a previous pilot study, a sample size of N = 75 is planned.

The Bayes Factor and visual analysis are used to continuously evaluate the intervention effect at the individual level. In the visual analysis, we look at level, trend, variability, immediacy, overlap, and consistency.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Primary Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The participants are assigned to one of the two possible intervention sequences: personalized CBT first and then standardized CBT, or in reverse order. In the personalized CBT, the participants will be allocated to one out of ten treatment modules according to their most relevant pain process. The same module will be used for the whole therapy phase.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

First standardized, second personalized CBT

In this study arm, patients will first receive standardized and then personalized CBT. In the standardized CBT phase, a standardized CBT protocol will take place. In the personalized intervention phase, person-specific networks are estimated. A network-based algorithm indicates the treatment target. Participants will receive one out of ten CBT modules addressing their treatment target. A hybrid therapy option, i.e., partially online, will be available. The decision lies with the respective therapists and will be documented as a variable.

Group Type EXPERIMENTAL

personalized Cognitive Behavior Therapy including third-wave

Intervention Type BEHAVIORAL

In the personalized CBT, patients first complete 21 days of EMA with six assessment points daily to assess relevant processes of CPP models. Person-specific networks are estimated based on the EMA data. A network-based algorithm indicates the treatment target. The individual CBT modules are selected for the participants from a matching matrix that contains experts' module recommendations for specific treatment targets. After that, participants will receive one out of ten CBT modules addressing their treatment target. All treatment modules are based on evaluated treatment manuals and contain methods from Cognitive Behavior Therapy, Acceptance and Commitment Therapy or Mindful Selfcompassion.

standardized Cognitive Behavior Therapy including third-wave

Intervention Type BEHAVIORAL

The standardized CBT intervention is manual-based and contains five sessions of cognitive behavioral therapy. Based on the evaluated manual from EFFECT Back, a short version with 5 modules is used: attention control, relaxation techniques, behavioral activation, cognitive strategies, and consolidation.

First personalized, second standardized CBT

In this study arm, patients will first receive standardized and then personalized CBT. In the personalized intervention phase, person-specific networks are estimated. A network-based algorithm indicates the treatment target. Participants will receive one out of ten CBT modules addressing their treatment target. In the standardized CBT phase, a manualized, standardized CBT will take place. A hybrid therapy option, i.e., partially online, will be available. The decision lies with the respective therapists and will be documented as a variable.

Group Type EXPERIMENTAL

personalized Cognitive Behavior Therapy including third-wave

Intervention Type BEHAVIORAL

In the personalized CBT, patients first complete 21 days of EMA with six assessment points daily to assess relevant processes of CPP models. Person-specific networks are estimated based on the EMA data. A network-based algorithm indicates the treatment target. The individual CBT modules are selected for the participants from a matching matrix that contains experts' module recommendations for specific treatment targets. After that, participants will receive one out of ten CBT modules addressing their treatment target. All treatment modules are based on evaluated treatment manuals and contain methods from Cognitive Behavior Therapy, Acceptance and Commitment Therapy or Mindful Selfcompassion.

standardized Cognitive Behavior Therapy including third-wave

Intervention Type BEHAVIORAL

The standardized CBT intervention is manual-based and contains five sessions of cognitive behavioral therapy. Based on the evaluated manual from EFFECT Back, a short version with 5 modules is used: attention control, relaxation techniques, behavioral activation, cognitive strategies, and consolidation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

personalized Cognitive Behavior Therapy including third-wave

In the personalized CBT, patients first complete 21 days of EMA with six assessment points daily to assess relevant processes of CPP models. Person-specific networks are estimated based on the EMA data. A network-based algorithm indicates the treatment target. The individual CBT modules are selected for the participants from a matching matrix that contains experts' module recommendations for specific treatment targets. After that, participants will receive one out of ten CBT modules addressing their treatment target. All treatment modules are based on evaluated treatment manuals and contain methods from Cognitive Behavior Therapy, Acceptance and Commitment Therapy or Mindful Selfcompassion.

Intervention Type BEHAVIORAL

standardized Cognitive Behavior Therapy including third-wave

The standardized CBT intervention is manual-based and contains five sessions of cognitive behavioral therapy. Based on the evaluated manual from EFFECT Back, a short version with 5 modules is used: attention control, relaxation techniques, behavioral activation, cognitive strategies, and consolidation.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* main diagnosis of chronic pain (i.e. pain persists for at least 6 months and is the most prominent/most burdensome symptom)
* subjective impairment/disability (yes-no)
* access to a smartphone compatible with the app mPath

Exclusion Criteria

* acute hazard due to suicidality, substance abuse, and/or psychosis
* only migraine/headache or migraine/headache are the focus of pain
* analphabetism
* insufficient German knowledge
* current psychotherapy
* current participation in another intervention study
* physical inability to take part in therapy and study sessions
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Prof. Dr. Julia Glombiewski

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Prof. Dr. Julia Glombiewski

Clinical professor, Head of department clinical psychology and psychotherapy for adults

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

RPTU Kaiserslautern-Landau, Klinische Psychologie und Psychotherapie des Erwachsenenalters

Landau, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Felicitas Kininger, M.Sc.

Role: CONTACT

+49 6431 280-356-53

Saskia Scholten, PhD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Felicitas Kininger, M.Sc.

Role: primary

Saskia Scholten, PhD

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Hofmann VE, Glombiewski JA, Kininger F, Scholten S. How to personalise cognitive-behavioural therapy for chronic primary pain using network analysis: study protocol for a single-case experimental design with multiple baselines. BMJ Open. 2024 Dec 3;14(12):e089319. doi: 10.1136/bmjopen-2024-089319.

Reference Type BACKGROUND
PMID: 39627123 (View on PubMed)

Vogt R, Haas J, Baumann L, Sander A, Klose C, Riecke J, Rief W, Bingel U, Maser D, Witthoft M, Kessler J, Zugaj MR, Ditzen B, Glombiewski JA. EFFects of Exposure and Cognitive behavioral Therapy for chronic BACK pain ("EFFECT-BACK"): study protocol for a randomized controlled trial. Trials. 2024 Mar 11;25(1):176. doi: 10.1186/s13063-024-08017-9.

Reference Type BACKGROUND
PMID: 38468293 (View on PubMed)

Vogel F, Blanken TF, Burger J, Reichert J, Scholten S, Klintwall L. How perceived causal networks can complement case conceptualization, diagnostic classification, and data-based networks: An introduction to a method for constructing personalized networks. J Psychopathol Clin Sci. 2025 Oct;134(7):844-854. doi: 10.1037/abn0001036. Epub 2025 Aug 14.

Reference Type BACKGROUND
PMID: 40811099 (View on PubMed)

Ustun TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, Saxena S, von Korff M, Pull C; WHO/NIH Joint Project. Developing the World Health Organization Disability Assessment Schedule 2.0. Bull World Health Organ. 2010 Nov 1;88(11):815-23. doi: 10.2471/BLT.09.067231. Epub 2010 May 20.

Reference Type BACKGROUND
PMID: 21076562 (View on PubMed)

Akerblom S, Perrin S, Rivano Fischer M, McCracken LM. Predictors and mediators of outcome in cognitive behavioral therapy for chronic pain: the contributions of psychological flexibility. J Behav Med. 2021 Feb;44(1):111-122. doi: 10.1007/s10865-020-00168-9. Epub 2020 Jul 8.

Reference Type BACKGROUND
PMID: 32642875 (View on PubMed)

Williams ACC, Fisher E, Hearn L, Eccleston C. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev. 2020 Aug 12;8(8):CD007407. doi: 10.1002/14651858.CD007407.pub4.

Reference Type BACKGROUND
PMID: 32794606 (View on PubMed)

Wright AGC, Woods WC. Personalized Models of Psychopathology. Annu Rev Clin Psychol. 2020 May 7;16:49-74. doi: 10.1146/annurev-clinpsy-102419-125032. Epub 2020 Feb 18.

Reference Type BACKGROUND
PMID: 32070120 (View on PubMed)

Vlaeyen JWS, Crombez G. Behavioral Conceptualization and Treatment of Chronic Pain. Annu Rev Clin Psychol. 2020 May 7;16:187-212. doi: 10.1146/annurev-clinpsy-050718-095744. Epub 2019 Dec 10.

Reference Type BACKGROUND
PMID: 31821023 (View on PubMed)

Wideman TH, Finan PH, Edwards RR, Quartana PJ, Buenaver LF, Haythornthwaite JA, Smith MT. Increased sensitivity to physical activity among individuals with knee osteoarthritis: relation to pain outcomes, psychological factors, and responses to quantitative sensory testing. Pain. 2014 Apr;155(4):703-711. doi: 10.1016/j.pain.2013.12.028. Epub 2013 Dec 28.

Reference Type BACKGROUND
PMID: 24378879 (View on PubMed)

Beeckman M, Simons LE, Hughes S, Loeys T, Goubert L. A Network Analysis of Potential Antecedents and Consequences of Pain-Related Activity Avoidance and Activity Engagement in Adolescents. Pain Med. 2020 Feb 1;21(2):e89-e101. doi: 10.1093/pm/pnz211.

Reference Type BACKGROUND
PMID: 31498397 (View on PubMed)

Liew BXW, Ford JJ, Briganti G, Hahne AJ. Understanding how individualised physiotherapy or advice altered different elements of disability for people with low back pain using network analysis. PLoS One. 2022 Feb 10;17(2):e0263574. doi: 10.1371/journal.pone.0263574. eCollection 2022.

Reference Type BACKGROUND
PMID: 35143552 (View on PubMed)

Thompson EL, Broadbent J, Fuller-Tyszkiewicz M, Bertino MD, Staiger PK. A Network Analysis of the Links Between Chronic Pain Symptoms and Affective Disorder Symptoms. Int J Behav Med. 2019 Feb;26(1):59-68. doi: 10.1007/s12529-018-9754-8.

Reference Type BACKGROUND
PMID: 30377989 (View on PubMed)

Borsboom D. A network theory of mental disorders. World Psychiatry. 2017 Feb;16(1):5-13. doi: 10.1002/wps.20375.

Reference Type BACKGROUND
PMID: 28127906 (View on PubMed)

Anderson KO, Dowds BN, Pelletz RE, Edwards TW, Peeters-Asdourian C. Development and initial validation of a scale to measure self-efficacy beliefs in patients with chronic pain. Pain. 1995 Oct;63(1):77-83. doi: 10.1016/0304-3959(95)00021-J.

Reference Type BACKGROUND
PMID: 8577493 (View on PubMed)

Nicholas MK. The pain self-efficacy questionnaire: Taking pain into account. Eur J Pain. 2007 Feb;11(2):153-63. doi: 10.1016/j.ejpain.2005.12.008. Epub 2006 Jan 30.

Reference Type BACKGROUND
PMID: 16446108 (View on PubMed)

Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, Hertz S, Jadad AR, Kramer LD, Manning DC, Martin S, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robbins W, Robinson JP, Rothman M, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Wernicke J, Witter J; IMMPACT. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005 Jan;113(1-2):9-19. doi: 10.1016/j.pain.2004.09.012. No abstract available.

Reference Type BACKGROUND
PMID: 15621359 (View on PubMed)

Tait RC, Chibnall JT, Krause S. The Pain Disability Index: psychometric properties. Pain. 1990 Feb;40(2):171-182. doi: 10.1016/0304-3959(90)90068-O.

Reference Type BACKGROUND
PMID: 2308763 (View on PubMed)

Mewes R, Rief W, Stenzel N, Glaesmer H, Martin A, Brahler E. What is "normal" disability? An investigation of disability in the general population. Pain. 2009 Mar;142(1-2):36-41. doi: 10.1016/j.pain.2008.11.007. Epub 2009 Jan 14.

Reference Type BACKGROUND
PMID: 19147292 (View on PubMed)

Sielski R, Glombiewski JA, Rief W, Crombez G, Barke A. Cross-cultural adaptation of the German Pain Solutions Questionnaire: an instrument to measure assimilative and accommodative coping in response to chronic pain. J Pain Res. 2017 Jun 19;10:1437-1446. doi: 10.2147/JPR.S130016. eCollection 2017.

Reference Type BACKGROUND
PMID: 28684921 (View on PubMed)

Germer CK, Neff KD. Self-compassion in clinical practice. J Clin Psychol. 2013 Aug;69(8):856-67. doi: 10.1002/jclp.22021. Epub 2013 Jun 17.

Reference Type BACKGROUND
PMID: 23775511 (View on PubMed)

Rozental A, Kottorp A, Forsstrom D, Mansson K, Boettcher J, Andersson G, Furmark T, Carlbring P. The Negative Effects Questionnaire: psychometric properties of an instrument for assessing negative effects in psychological treatments. Behav Cogn Psychother. 2019 Sep;47(5):559-572. doi: 10.1017/S1352465819000018. Epub 2019 Mar 15.

Reference Type BACKGROUND
PMID: 30871650 (View on PubMed)

Munder T, Wilmers F, Leonhart R, Linster HW, Barth J. Working Alliance Inventory-Short Revised (WAI-SR): psychometric properties in outpatients and inpatients. Clin Psychol Psychother. 2010 May-Jun;17(3):231-9. doi: 10.1002/cpp.658.

Reference Type BACKGROUND
PMID: 20013760 (View on PubMed)

Guest G, Bunce A, & Johnson L. How many interviews are enough?: An experiment with data saturation and variability. Field Methods. 2006; 18(1): 59-82. https://doi.org/10.1177/1525822X05279903

Reference Type BACKGROUND

Morley S. Single-case methods in clinical psychology A practical guide (C. M., & C. J. M., Eds.). Routledge. 2018.

Reference Type BACKGROUND

Margraf J, Cwik JC, Suppiger A, & Schneider S. Mini-DIPS Open Access. Diagnostisches Interview bei psychischen Störungen [Short-Form of the Diagnostic Interview for Mental Disorders. Open Access]. 2017. https://www.kli.psy.ruhr-uni-bochum.de/dips-interv/klipsy/download/Mini-DIPS%20Open%20Access.pdf

Reference Type BACKGROUND

Green P, & MacLeod CJ. SIMR : an R package for power analysis of generalized linear mixed models by simulation. Methods in Ecology and Evolution. 2016; 7(4): 493-498. https://doi.org/10.1111/2041-210X.12504

Reference Type BACKGROUND

Nubling R, Kraft M, Henn J, Kriz D, Lutz W, Schmidt J, Wittmann W, Bassler M. [Testing the Psychometric Properties of the Helping Alliance Questionnaire (HAQ) in Different Health Care Settings]. Psychother Psychosom Med Psychol. 2017 Nov;67(11):465-476. doi: 10.1055/s-0043-111083. Epub 2017 Aug 30. German.

Reference Type BACKGROUND
PMID: 28854445 (View on PubMed)

Schulte D. Messung der Therapieerwartung und Therapieevaluation von Patienten (PATHEV). Zeitschrift für Klinische Psychologie und Psychotherapie. 2005; 34(3): 176-187. https://doi.org/10.1026/1616-3443.34.3.176

Reference Type BACKGROUND

Mangels M, Schwarz S, Sohr G, Holme M, & Rief W. Der Fragebogen zur Erfassung der schmerzspezifischen Selbstwirksamkeit (FESS): Eine Adaptation des Pain Self-Efficacy Questionnaire für den deutschen Sprachraum. Diagnostica. 2009; 55(2): 84-93. https://doi.org/10.1026/0012-1924.55.2.84

Reference Type BACKGROUND

McCracken LM. Contextual cognitive-behavioral therapy for chronic pain. IASP Press. 2005.

Reference Type BACKGROUND

Nicholas M, Molloy A, Tonkin L, & Beeston L. Practical and positive ways of adapting to chronic pain Manage your pain. Souvenir press. 2003.

Reference Type BACKGROUND

Kleinstäuber M, Thomas P, Witthöft M, & Hiller W. Kognitive Verhaltenstherapie bei medizinisch unerklärten Körperbeschwerden und somatoformen Störungen (2. Aufl.). Springer. 2018.

Reference Type BACKGROUND

Germer CK, & Neff KD. Mindful Self-Compassion (MSC). In I. Itzvan (Ed.), The handbook of mindfulness-based programs: Every established intervention, from medicine to education. 2019;(357-367). Routledge.

Reference Type BACKGROUND

Main CJ, Keefe FJ, Jensen MP, Vlaeyen JWS, & Vowles KE. Fordyce's Behavioral Methods for Chronic Pain And Illness Republished with Invited Commentaries. IASP Press. 2015.

Reference Type BACKGROUND

de Vries RM, Morey RD. Bayesian hypothesis testing for single-subject designs. Psychol Methods. 2013 Jun;18(2):165-85. doi: 10.1037/a0031037. Epub 2013 Mar 4.

Reference Type BACKGROUND
PMID: 23458719 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

https://doi.org/10.17605/OSF.IO/BNFWY

Preregistration of the algorithmic decision-tool

https://doi.org/10.17605/OSF.IO/S4RMN

Preregistration of the EMA questionnaire development

https://clinicaltrials.gov/study/NCT06179784

Preregistration of the feasibility study POINT Pain

https://m-path.io/landing/

Assessment app mPath

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

POINT Pain 2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

3h of PNE on BDNF and Pain Levels
NCT05736172 RECRUITING NA